ribavirin
Term · Oncology and biomedicine · MLC-T-ONC-007438
A drug used to treat respiratory syncytial virus (RSV) infection in the lungs.
A synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. Ribavirin is incorporated into viral RNA, thereby inhibiting viral RNA synthesis, inducing viral genome mutations, and inhibiting normal viral replication.
| Identifier | MLC-T-ONC-007438 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | RTCA |
| Synonyms | viramide |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-007438",
"term": "ribavirin",
"field": "Oncology and biomedicine",
"definitions": [
"A drug used to treat respiratory syncytial virus (RSV) infection in the lungs.",
"A synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. Ribavirin is incorporated into viral RNA, thereby inhibiting viral RNA synthesis, inducing viral genome mutations, and inhibiting normal viral replication."
],
"abbreviation": "RTCA",
"synonyms": [
"viramide"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ribavirin/"
}
Record 14,460 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.